The Impact of Previous HBV Infection on The Severity of Nonalcoholic Fatty Liver Disease
Abdelrazek, F., Abdel Baki, A., Abdellatif, S., Eliwa, A., Elgendar, M. (2646). The Impact of Previous HBV Infection on The Severity of Nonalcoholic Fatty Liver Disease. EKB Journal Management System, 2024(12), -. doi: 10.58675/2682-339X.2829
Fathy Abdelrazek; Amin Abdel Baki; Salama Abdellatif; Ahmed Eliwa; Mohammed Elgendar. "The Impact of Previous HBV Infection on The Severity of Nonalcoholic Fatty Liver Disease". EKB Journal Management System, 2024, 12, 2646, -. doi: 10.58675/2682-339X.2829
Abdelrazek, F., Abdel Baki, A., Abdellatif, S., Eliwa, A., Elgendar, M. (2646). 'The Impact of Previous HBV Infection on The Severity of Nonalcoholic Fatty Liver Disease', EKB Journal Management System, 2024(12), pp. -. doi: 10.58675/2682-339X.2829
Abdelrazek, F., Abdel Baki, A., Abdellatif, S., Eliwa, A., Elgendar, M. The Impact of Previous HBV Infection on The Severity of Nonalcoholic Fatty Liver Disease. EKB Journal Management System, 2646; 2024(12): -. doi: 10.58675/2682-339X.2829

The Impact of Previous HBV Infection on The Severity of Nonalcoholic Fatty Liver Disease

Al-Azhar International Medical Journal
Volume 2024, Issue 12, December 2024  XML
DOI: 10.58675/2682-339X.2829
View on SCiNiTO View on SCiNiTO
Authors
Fathy Abdelrazek1; Amin Abdel Baki2; Salama Abdellatif3; Ahmed Eliwa4; Mohammed Elgendar4
1Internal Medicine, and Gastroenterology Departement, Faculty of Medicine - Al-Azhar University, Cairo, Egypt
2Gastroenterology and Hepatology, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt
3Clinical Pathology, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt
4Internal Medicine, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) one of principalreasons of cirrhosis and hepatocellular carcinoma (HCC), it impacts a minimum of 25% of the adult population worldwide. During active phase of HBV infection, patients who have previously contracted the virus may encounter liver damage. Additionally, HBV DNA incorporation into host genome may elevate likelihood of HCC. Aim: Detect the connection between NAFLD severity and prior HBV infection. Methods: This cross-sectional research was executed on 50 metabolic dysfunction–associated fatty liver diseas (MAFLD) patients, two groups of subjects were formed: Group A: 40 negative Anti-HBc patients and group B: 10 positive Anti-HBc patients. Results: The fibrosis-4 (FIB-4) scores, indicative of liver fibrosis, are significantly greater in Group B, with a mean score of 2.97 compared to 0.98 in Group A. The Fibroscan results reinforce the presence of more advanced fibrosis in Group B, where a higher proportion of patients exhibit stages F2 and F3 fibrosis compared to Group A. Specifically, Group B has a larger percentage of patients with higher degrees of fibrosis, including stages F3. In multivariate analysis, positive Anti-HBc status remained a significant predictor of high-grade fibrosis. Conclusions: Positive Anti-HBc status stayed a significant predictor of high-grade fibrosis. MAFLD patients who had positive anti-HBc have a greater probability of having severe fibrosis than those who had negative anti-HBc.
Statistics
Article View: 19